Malignant Thoracic Neoplasm — Trials

Malignant Thoracic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,501 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,775
Recruiting: 1,498
Ph III recruiting: 183
Growth YoY: +7%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,528)

clinicaltrialsPublishedShowing 851–900 of 1,944 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06950697	Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors	recruiting	—	2,400	Beijing Chao Yang HospitalOTHER	1	Apr 30, 2026	clinicaltrials
NCT07279402	TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%	recruiting	—	150	Antalya Training and Research HospitalOTHER_GOV	1	Apr 30, 2026